Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Cancer Vaccine Biotech CimCure Raises € 5 Million in Seed Round Investment Led by Positron Ventures
CimCure, a biotech spin-off of Amsterdam UMC, focusing on the development of a novel vaccine-based […]
Epic Sciences Raises $43M in First Close of Series F Financing to Advance Comprehensive Profiling for Metastatic Cancer Patients
Epic Sciences, Inc. (“Epic” or “Epic Sciences”), a privately held diagnostics company, has completed a $43 […]
Florence Raises $35 Million (£28.5m) to Revolutionise Social Care Staffing
Florence, the UK-based tech innovator for social care, announced it has raised $35 million (£28.5m) […]
Aruna Bio Advances Therapeutic Development for Traumatic Brain Injury
Aruna Bio, Inc., a leader in the development of neural exosome based therapeutics for the […]
Transine Therapeutics Announces Final Closing of its Seed Round at £13.7m to Accelerate its Platform and Portfolio Development
Transine Therapeutics (‘Transine’), a biotechnology company developing a novel class of therapeutic RNAs based on […]
Full-Life Technologies Completes $37 Million (USD) Series A Financing to Accelerate Development of its Radiopharmaceutical Pipeline and Radiotechnology Production Platform
Full-Life Technologies (“Full-Life”) today announced it completed a $37 million (USD) Series A financing round to advance […]
InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers
InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and drug […]
Curebase Secures $40 Million in Series B Funding
Curebase, a company committed to democratizing access to clinical studies, has raised $40 million in […]
AdBio Partners Welcomes Inserm Transfert As Investor in Second Fund – AFB Fund II
AdBio partners, an AMF-regulated (the French financial market authority) investment company dedicated to life sciences, […]
HealthBeats Raises US$3m Seed Funding Led By Heritas Capital And SEEDS Capital To Expand Remote Vitals Monitoring In Australia And Singapore
HealthBeatsTM, a Singapore-based healthtech start-up with end-to-end remote vitals monitoring solution, today announced the close of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more